PETV Stock Overview A biomedical device company, manufactures, commercializes, and licenses medical devices and therapeutics for animals. More details
Risk Analysis + 2 more risks
See All Risk Checks Capture your thoughts, links and company narrative
PetVivo Holdings, Inc. Competitors Price History & Performance
Summary of share price highs, lows and changes for PetVivo Holdings Historical stock prices Current Share Price US$0.50 52 Week High US$1.50 52 Week Low US$0.29 Beta 2.43 1 Month Change 5.84% 3 Month Change 8.72% 1 Year Change -52.82% 3 Year Change -87.27% 5 Year Change -72.22% Change since IPO -99.41%
Recent News & Updates
PetVivo Holdings, Inc. Reiterates Revenue Guidance for the Year 2025 Nov 15
PetVivo Holdings, Inc. to Report Q2, 2025 Results on Nov 14, 2024 Nov 11
PetVivo Holdings, Inc. Appoints Mike Eldred as Member of Board Sep 26
Nasdaq Files Form 25 to Delist Securities of PetVivo Holdings Sep 09 The Nasdaq Stock Market to Delist Common Stock of PetVivo Holdings Sep 06
PetVivo Holdings, Inc. Reiterates Revenue Guidance for the Full Year 2025 Aug 15 See more updates
PetVivo Holdings, Inc. Reiterates Revenue Guidance for the Year 2025 Nov 15
PetVivo Holdings, Inc. to Report Q2, 2025 Results on Nov 14, 2024 Nov 11
PetVivo Holdings, Inc. Appoints Mike Eldred as Member of Board Sep 26
Nasdaq Files Form 25 to Delist Securities of PetVivo Holdings Sep 09 The Nasdaq Stock Market to Delist Common Stock of PetVivo Holdings Sep 06
PetVivo Holdings, Inc. Reiterates Revenue Guidance for the Full Year 2025 Aug 15
PetVivo Holdings, Inc. to Report Q1, 2025 Results on Aug 14, 2024 Aug 08
PetVivo Holdings Receives a Non-Compliance Letter from the Nasdaq Stock Market Jul 29 PetVivo Holdings, Inc. announced that it has received $1.21 million in funding Jul 17
PetVivo Holdings, Inc. to Report Q4, 2024 Results on Jun 28, 2024 Jun 26
PetVivo Holdings, Inc.(OTCPK:PETV) dropped from S&P TMI Index Apr 11
PetVivo Holdings Receives Determination Letter from the Nasdaq Hearings Panel Due to Failure to Regain Compliance with the Nasdaq Listing Rule 5550(b) by April 1, 2024 Apr 10 PetVivo Holdings, Inc.(OTCPK:PETV) dropped from NASDAQ Composite Index Apr 09
Petvivo Holdings, Inc. Appoints Garry Lowenthal as Its New Chief Financial Officer Mar 11 PetVivo Holdings, Inc. has completed a Follow-on Equity Offering in the amount of $0.959033 million. Mar 08
Third quarter 2024 earnings released: US$0.12 loss per share (vs US$0.23 loss in 3Q 2023) Feb 14
PetVivo Holdings, Inc. to Report Q3, 2024 Results on Feb 12, 2024 Feb 07
PetVivo Holdings, Inc. Announces Release of Clinical Study Results Involving Canine Tolerance to Intra-Articular Injections of Spryng with OsteoCushion Technology Feb 01
Petvivo Receives Notice of Allowance from United States Patent and Trademark Office for Key Patent Application Jan 23
PetVivo Holdings Receives Written Notice from Nasdaq Regarding Non-Compliance with the Minimum Stockholders’ Equity Requirement Under Nasdaq Listing Rule 5550(b)(1) Nov 25
New major risk - Market cap size Nov 24
PetVivo Holdings, Inc. Approves Election of Diane Levitan as Member of the Board Nov 23
New major risk - Financial position Nov 17
Second quarter 2024 earnings released: US$0.28 loss per share (vs US$0.21 loss in 2Q 2023) Nov 17
PetVivo Holdings, Inc. to Report Q2, 2024 Results on Nov 14, 2023 Nov 10
PetVivo Holdings, Inc., Annual General Meeting, Nov 17, 2023 Sep 06
Independent Chairman of the Board recently bought US$51k worth of stock Aug 24
PetVivo Receives Notice of Allowance from United States Patent and Trademark Office for Key Patent Application Aug 18
First quarter 2024 earnings released: US$0.25 loss per share (vs US$0.20 loss in 1Q 2023) Aug 13
PetVivo Holdings, Inc. to Report Q1, 2024 Results on Aug 10, 2023 Aug 08
New minor risk - Share price stability Jul 05
Full year 2023 earnings: EPS and revenues miss analyst expectations Jul 01
PetVivo Holdings, Inc. to Report Fiscal Year 2023 Results on Jun 29, 2023 Jun 27
PetVivo Holdings, Inc. Begins Process to Pursue Approval of Biomatrix Particulate Technology for Initial Human Indication Jun 22
Third quarter 2023 earnings released: US$0.23 loss per share (vs US$0.17 loss in 3Q 2022) Feb 10
PetVivo Holdings, Inc. to Report Q3, 2023 Results on Feb 09, 2023 Feb 03
Second quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind Nov 16
Second quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind Nov 12
Companies Like PetVivo Holdings (NASDAQ:PETV) Could Be Quite Risky Nov 11
PetVivo Holdings, Inc. to Report Q2, 2023 Results on Nov 10, 2022 Nov 04
Petvivo Holding, Inc. Announces Spryng™ Now Available to Veternarians Through Mwi Animal Health Oct 04
PetVivo Holdings, Inc., Annual General Meeting, Oct 14, 2022 Aug 27
First quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind Aug 12
PetVivo Holdings, Inc. to Report Q1, 2023 Results on Aug 11, 2022 Aug 09
PetVivo Holdings, Inc. Announces Board Appointments Aug 02
Will PetVivo Holdings (NASDAQ:PETV) Spend Its Cash Wisely? Jul 26
PetVivo Holdings GAAP EPS of -$0.57 beats by $0.37, revenue of $0.1M misses by $1.6M Jun 29
Full year 2022 earnings: EPS and revenues miss analyst expectations Jun 25
PetVivo Holdings, Inc. to Report Fiscal Year 2022 Results on Jun 29, 2022 Jun 22
We Think PetVivo Holdings (NASDAQ:PETV) Can Afford To Drive Business Growth Mar 23
Third quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind Feb 12
PetVivo Holdings, Inc. to Report Q3, 2022 Results on Feb 10, 2022 Feb 04
Second quarter 2022 earnings released: US$0.13 loss per share (vs US$0.23 loss in 2Q 2021) Nov 17
First quarter 2022 earnings released: US$0.071 loss per share (vs US$0.14 loss in 1Q 2021) Aug 18 PetVivo Holdings Common Stock Deleted from Other OTC
High number of new directors Aug 12
Petvivo Holdings, Inc. Enters into University Services Agreement with Colorado State University Nov 13
PetVivo Holdings, Inc. announced that it has received $0.6 million in funding from RedDiamond Partners LLC Sep 24
Petvivo Holdings, Inc. Appoints Dr. David B. Masters as Director of Science and Technology Sep 19 Shareholder Returns PETV US Medical Equipment US Market 7D -0.9% -0.8% -1.1% 1Y -52.8% 8.4% 22.4%
See full shareholder returns
Return vs Market: PETV underperformed the US Market which returned 23.7% over the past year.
Price Volatility Is PETV's price volatile compared to industry and market? PETV volatility PETV Average Weekly Movement 13.0% Medical Equipment Industry Average Movement 8.0% Market Average Movement 6.3% 10% most volatile stocks in US Market 17.6% 10% least volatile stocks in US Market 3.1%
Stable Share Price: PETV's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: PETV's weekly volatility (13%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company PetVivo Holdings, Inc., a biomedical device company, manufactures, commercializes, and licenses medical devices and therapeutics for animals. Its lead product is Spryng, a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions, such as osteoarthritis in dogs and horses. The company’s pipeline products also include therapeutic devices for veterinary and human clinical applications.
Show more PetVivo Holdings, Inc. Fundamentals Summary How do PetVivo Holdings's earnings and revenue compare to its market cap? PETV fundamental statistics Market cap US$11.32m Earnings (TTM ) -US$8.62m Revenue (TTM ) US$968.63k
Earnings & Revenue Key profitability statistics from the latest earnings report (TTM) PETV income statement (TTM ) Revenue US$968.63k Cost of Revenue US$229.17k Gross Profit US$739.46k Other Expenses US$9.36m Earnings -US$8.62m
Last Reported Earnings
Sep 30, 2024
Earnings per share (EPS) -0.42 Gross Margin 76.34% Net Profit Margin -890.24% Debt/Equity Ratio 126.7%
How did PETV perform over the long term?
See historical performance and comparison
Company Analysis and Financial Data Status Data Last Updated (UTC time) Company Analysis 2024/12/30 16:25 End of Day Share Price 2024/12/30 00:00 Earnings 2024/09/30 Annual Earnings 2024/03/31
Data Sources The data used in our company analysis is from S&P Global Market Intelligence LLC . The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package Data Timeframe Example US Source * Company Financials 10 years Income statement Cash flow statement Balance sheet Analyst Consensus Estimates +3 years Forecast financials Analyst price targets Market Prices 30 years Stock prices Dividends, Splits and Actions Ownership 10 years Top shareholders Insider trading Management 10 years Leadership team Board of directors Key Developments 10 years
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here .
Analysis Model and Snowflake Details of the analysis model used to generate this report is available on our Github page , we also have guides on how to use our reports and tutorials on Youtube .
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources PetVivo Holdings, Inc. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst Institution Ashok Kumar ThinkEquity LLC
Show 0 more analysts 
